Research graph
References from Translating molecular thrombus imaging into clinical practice: scientific promise, practical barriers, and pragmatic solutions. Local targets link to admitted publications; unresolved targets remain external evidence.
Nuclear molecular imaging of venous thromboembolism: targeting clot-specific molecular components for improved diagnosis and management
10.1016/j.jtha.2026.05.031 · 2026 · External reference
18F-GP1, a novel PET tracer designed for high-sensitivity, low-background detection of thrombi
10.2967/jnumed.116.188896 · 2017 · External reference
In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
10.1186/s12951-022-01648-7 · 2022 · External reference
Fluorine-19 magnetic resonance imaging of activated platelets
10.1161/jaha.120.016971 · 2020 · External reference
A unique recombinant fluoroprobe targeting activated platelets allows in vivo detection of arterial thrombosis and pulmonary embolism using a novel three-dimensional fluorescence emission computed tomography (FLECT) technology
10.7150/thno.18099 · 2017 · External reference
Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice
10.1161/circulationaha.111.030312 · 2012 · External reference
Pharmaceutical development and safety evaluation of a GMP-grade fucoidan for molecular diagnosis of cardiovascular diseases
10.3390/md17120699 · 2019 · External reference
First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectin
10.1186/s13550-024-01173-8 · 2024 · External reference
Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model
10.1055/s-2007-963573 · 2007 · External reference
Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes
10.1016/j.omtn.2023.01.009 · 2023 · External reference
Activated coagulation FXII: a unique target for in vivo molecular imaging
10.1161/atvbaha.122.318883 · 2023 · External reference
Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer
10.1093/ehjci/jez207 · 2020 · External reference
High-resolution imaging of myeloperoxidase activity sensors in human cerebrovascular disease
10.1038/s41598-018-25804-y · 2018 · External reference
VCAM-1-targeted MRI improves detection of the tumor-brain interface
10.1158/1078-0432.ccr-21-4011 · 2022 · External reference
Head-to-head comparison of 11C-PBR28 and 18F-GE180 for quantification of the translocator protein in the human brain
10.2967/jnumed.117.203109 · 2018 · External reference
MRI quantitative T2∗ mapping to predict dominant composition of in vitro thrombus
10.3174/ajnr.a5938 · 2019 · External reference
Sensitive magnetic particle imaging of haemoglobin degradation for the detection and monitoring of intraplaque haemorrhage in atherosclerosis
10.1016/j.ebiom.2023.104509 · 2023 · External reference
Expression of fibroblast activation protein-alpha in human deep vein thrombosis
10.1016/j.thromres.2024.109075 · 2024 · External reference
Pulmonary artery imaging with 68Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension
10.1007/s12350-022-03069-3 · 2023 · External reference
Diagnosis of recurrent venous thromboembolism
10.1016/j.thromres.2017.05.026 · 2018 · External reference
Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis
10.1056/nejmoa1615066 · 2017 · External reference
Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial
10.1161/circulationaha.124.072364 · 2025 · External reference
Thrombus structural composition in cardiovascular disease
10.1161/atvbaha.120.315754 · 2021 · External reference
